ESMO 2025: Faeth Therapeutics’ Phase 2 DICE Trial Shows 34% Reduction in Risk of Disease Progression with Oral Sapanisertib Plus Chemotherapy 
Blockpass and RWA Inc. Partner to Effect Verifiable Trust in Real World Asset & DePIN Tokenization Green Apple Pediatric Dentistry Wins Synchrony Pillars Award
Small Business Honored for Supporting Its Community Through Times of Change AUSTIN, TX / ACCESSWIRE…
Rockland Trust Named Honoree of Global Finance’s Outstanding Crisis Leadership Program
HANOVER, MA / ACCESSWIRE /Â November 10, 2020 /Â Global Finance has honored Rockland Trust for Outstanding…
Network Operators Risk Missing “Massive Opportunity” To Drive Change Says Upstream at AfricaCom 2020
Upstream’s Chief Commercial Officer, Raul Martinez, outlines the importance of diversifying revenue streams & exploring…
Half of all NHS trusts in England opt for UK tech company StarLeaf over video conferencing rivals
Watford-headquartered StarLeaf is a privacy-centric, British competitor to Zoom Over 100 NHS organisations across England…
CREST International and CMMC Center of Excellence Announce Memorandum of Understanding
11 November 2020: CREST International and the Cybersecurity Maturity Model Certification Center of Excellence (CMMC…
Lumu Introduces Lightweight Solution to Improve Security for Remote Workforce
New Lumu Agent for Windows Works Silently to Measure Remote Worker Compromise Levels in Real Time…
Zealand Pharma:
Press Release – No. 53 / 2020 Zealand Pharma to participate in upcoming investor conferences…
Tiziana Life Sciences announces collaboration with Parexel Biotech to conduct phase 1b/2 clinical trial in patients with Crohn’s Disease
First Ever Study with take-home capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody Potential…
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, November 11, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today…
Bavarian Nordic Announces Interim Results for the First Nine Months of 2020
COPENHAGEN, Denmark, November 11, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
PCI Biotech third quarter 2020 results
Oslo (Norway), 11 November 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company,…
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
MENLO PARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:…
Organogenesis Holdings Inc. Announces Proposed Public Offering of Class A Common Stock
CANTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Golden Leaf Holdings to Report Third Quarter Earnings
TORONTO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (“Golden Leaf” or the…
Keros Therapeutics Announces Proposed Public Offering of Common Stock
LEXINGTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
Vaxcyte to Present at Jefferies Virtual London Healthcare Conference
FOSTER CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Vaxcyte, Inc., formerly known as SutroVax,…
Turning Point Therapeutics to Participate in Jefferies Virtual London Healthcare Conference
SAN DIEGO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference
EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”),…
Clinical Genomics to Present at 2020 Canaccord Genuity Virtual Medical Technologies & Diagnostics Forum
BRIDGEWATER, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) — Clinical Genomics (“CG” or the “Company”), a…
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2020 Financial Results
LEXINGTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”)…